FEMY insider buying and SEC filings, explained
Femasys Inc. · CIK 1339005
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$134K
Insiders who bought
5
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Aug 7, 2026 | Purchase (code P) | Jeffrey Gerald Mifek (Chief Clinical-Medical Affairs) bought 3,125 shares at $3.20 ($10K), reported as a purchase (code P). New position of 3,125 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 11, 2026 |
| Aug 7, 2026 | Purchase (code P) | Jeremy Alexander Sipos (Chief Technology Officer) bought 3,125 shares at $3.20 ($10K), reported as a purchase (code P). New position of 3,125 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 11, 2026 |
| Aug 7, 2026 | Purchase (code P) | John Charles Canning (President / COO) bought 4,375 shares at $3.20 ($14K), reported as a purchase (code P). New position of 4,375 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 11, 2026 |
| Aug 7, 2026 | Purchase (code P) | Dov Elefant (CFO) bought 15,625 shares at $3.20 ($50K), reported as a purchase (code P). New position of 15,625 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 11, 2026 |
| Aug 7, 2026 | Purchase (code P) | Kathy Lee-Sepsick (CEO and Director) bought 15,625 shares at $3.20 ($50K), reported as a purchase (code P). New position of 15,625 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 11, 2026 |
22 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
5 insiders bought in 30 days
$134K in purchases since Aug 7, 2026 · Purchases traded Aug 7, 2026 to Aug 7, 2026 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Kathy Lee-Sepsick (CEO) | $50K | Aug 7, 2026 | SEC filing |
| Dov Elefant (CFO) | $50K | Aug 7, 2026 | SEC filing |
| John Charles Canning (President / COO) | $14K | Aug 7, 2026 | SEC filing |
| Jeremy Alexander Sipos (Chief Technology Officer) | $10K | Aug 7, 2026 | SEC filing |
| Jeffrey Gerald Mifek (Chief Clinical-Medical Affairs) | $10K | Aug 7, 2026 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 2, 2026, 4:15 PM ET 8-K | Executive or director change (Item 5.02) Reg FD disclosure (Item 7.01) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow FEMY in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.